Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123336822 | 12333682 | 2 | F | 20150209 | 20160801 | 20160504 | 20160809 | EXP | US-ASTRAZENECA-2016SE46172 | ASTRAZENECA | 24247.00 | DY | F | Y | 60.30000 | KG | 20160809 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123336822 | 12333682 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2PUFFS BID | UNKNOWN | 21929 | |||||||||
| 123336822 | 12333682 | 2 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | UNKNOWN | 0 | 50 | MG | QD | |||||||
| 123336822 | 12333682 | 3 | C | OXYGEN. | OXYGEN | 1 | Respiratory (inhalation) | 2.0L AS REQUIRED | UNKNOWN | 0 | 2 | L | |||||||
| 123336822 | 12333682 | 4 | C | VALSARTAN. | VALSARTAN | 1 | Oral | UNKNOWN | 0 | 80 | MG | QD | |||||||
| 123336822 | 12333682 | 5 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | UNKNOWN | 0 | 100 | MG | BID | |||||||
| 123336822 | 12333682 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | UNKNOWN | 0 | 5 | MG | QD | |||||||
| 123336822 | 12333682 | 7 | C | PANTOTRAZOLE | 2 | Oral | UNKNOWN | 0 | 40 | MG | QD | ||||||||
| 123336822 | 12333682 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | UNKNOWN | 0 | 80 | MG | QD | |||||||
| 123336822 | 12333682 | 9 | C | XOPENEX RESCUE INHALER | 2 | Respiratory (inhalation) | AS REQUIRED | UNKNOWN | 0 | ||||||||||
| 123336822 | 12333682 | 10 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123336822 | 12333682 | 1 | Chronic obstructive pulmonary disease |
| 123336822 | 12333682 | 3 | Chronic obstructive pulmonary disease |
| 123336822 | 12333682 | 5 | Kidney infection |
| 123336822 | 12333682 | 9 | Dyspnoea |
| 123336822 | 12333682 | 10 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123336822 | 12333682 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123336822 | 12333682 | Dyspnoea | |
| 123336822 | 12333682 | Kidney infection | |
| 123336822 | 12333682 | Myocardial infarction | |
| 123336822 | 12333682 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123336822 | 12333682 | 1 | 2006 | 0 | ||
| 123336822 | 12333682 | 2 | 2015 | 0 | ||
| 123336822 | 12333682 | 3 | 20150209 | 0 | ||
| 123336822 | 12333682 | 4 | 2015 | 0 | ||
| 123336822 | 12333682 | 5 | 20160421 | 0 | ||
| 123336822 | 12333682 | 6 | 2015 | 0 | ||
| 123336822 | 12333682 | 7 | 2015 | 0 | ||
| 123336822 | 12333682 | 8 | 2015 | 0 | ||
| 123336822 | 12333682 | 9 | 2015 | 0 | ||
| 123336822 | 12333682 | 10 | 20150310 | 0 |